Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, NE, CNR 3021, Atlanta, GA, 30322, USA.
Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Rev Endocr Metab Disord. 2018 Sep;19(3):263-269. doi: 10.1007/s11154-018-9461-4.
A key priority of transgender health research is the evaluation of long-term effects of gender affirmation treatment. Thus, accurate assessment of treatment receipt is critical. The data for this analysis came from an electronic medical records (EMR) based cohort of transgender individuals. A subset of cohort members were also asked to complete a self-administered survey. Information from the EMR was compared with survey responses to assess the extent of agreement regarding transmasculine (TM)/transfeminine (TF) status, hormone therapy receipt, and type of surgery performed. Logistic regression models were used to assess whether participant characteristics were associated with disagreement between data sources. Agreement between EMR and survey-derived information was high regarding TM/TF status (99%) and hormone therapy receipt (97%). Lower agreement was observed for chest reconstruction surgery (72%) and genital reconstruction surgery (84%). Using survey responses as the "gold standard", both chest and genital reconstruction surgeries had high specificity (95 and 93%, respectively), but the corresponding sensitivities were low (49 and 68%, respectively). A lower proportion of TM had concordant results for chest reconstruction surgery (64% versus 79% for TF) while genital reconstruction surgery concordance was lower among TF (79% versus 89% for TM). For both surgery types, agreement was highest among the youngest participants. Our findings offer assurance that EMR-based data appropriately classify cohort participants with respect to their TM/TF status or hormone therapy receipt. However, current EMR data may not capture the complete history of gender affirmation surgeries. This information is useful in future studies of outcomes related to gender affirming therapy.
transgender 健康研究的一个主要重点是评估性别肯定治疗的长期效果。因此,准确评估治疗的接受情况至关重要。本分析的数据来自基于电子病历(EMR)的 transgender 个体队列。队列成员的一部分还被要求完成一份自我管理的调查。将 EMR 中的信息与调查结果进行比较,以评估关于跨性别男性(TM)/跨性别女性(TF)状态、激素治疗接受情况和进行的手术类型的一致性程度。使用逻辑回归模型评估参与者特征是否与数据源之间的不一致有关。EMR 和调查得出的信息在 TM/TF 状态(99%)和激素治疗接受情况(97%)方面高度一致。在胸部重建手术(72%)和生殖器重建手术(84%)方面观察到的一致性较低。使用调查结果作为“金标准”,胸部和生殖器重建手术均具有高特异性(分别为 95%和 93%),但相应的敏感性较低(分别为 49%和 68%)。TM 进行胸部重建手术的结果一致性较低(64%对 TF 的 79%),而 TF 进行生殖器重建手术的一致性较低(79%对 TM 的 89%)。对于这两种手术类型,年龄最小的参与者的一致性最高。我们的发现保证了 EMR 数据能够适当分类队列参与者的 TM/TF 状态或激素治疗接受情况。然而,目前的 EMR 数据可能无法捕捉到性别肯定手术的完整历史。这些信息对于未来与性别肯定治疗相关的结果研究很有用。